Biomedicine & Pharmacotherapy · 2019 · 55 citations · 34 references
MedicinePharmacologyToxicologyCancer PharmacologyChemotherapyMolecular OncologyCytotoxic ChemotherapyKidney CancerNephrotoxicity MechanismsRenal ProtectionRenal ToxicityBioactive Plant CompoundsChemotherapy-associated NephrotoxicityHerbal Medicine NephrotoxicityHerbal NephrotoxicityNephrotoxic Plant CompoundsNuclear Factor Kappa B InhibitionNuclear Factor Kappa B SignalingPlatinum-based Chemotherapy Renal Toxicity
8.136 μg/mL. In vivo nephroprotective activity was evaluated by administering CM (200 and 400 mg/kg, p.o) to rats for 10 days followed by single intraperitonial injection of CP (7.5 mg/kg) on the 5th day of the experiment. Nephrotoxicity induced by CP was apparent by elevated levels of serum and urine kidney function markers, transaminases, oxidative stress markers and histopathological alterations in kidney. Pre-treatment with CM normalized the renal function at both the doses by ameliorating the CP-induced renal damage markers, oxidative stress and histopathological variations. In-silico studies showed that, out of the thirty bioactive compounds, isovitexin and gallic acid exhibited a higher docking score of -22.467, -21.167 kcal/mol against NF-κB. Cianidanol and epicatechin exhibited a higher docking score of -14.234, -14.209 kcal/mol against sEH. The protective effect of CM extract in CP-induced nephrotoxicity might be attributed to its antioxidant, anti-inflammatory activity by inhibiting NF-κB and sEH upregulation.
34